These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 33649834)
1. SIRT1 and gynecological malignancies (Review). Chen J; Chen H; Pan L Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649834 [TBL] [Abstract][Full Text] [Related]
2. SIRT1-mediated deacetylation of FOXO3 enhances mitophagy and drives hormone resistance in endometrial cancer. Wei X; Xiong X; Wang P; Zhang S; Peng D Mol Med; 2024 Sep; 30(1):147. PubMed ID: 39266959 [TBL] [Abstract][Full Text] [Related]
3. SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Zhang T; Kraus WL Biochim Biophys Acta; 2010 Aug; 1804(8):1666-75. PubMed ID: 19879981 [TBL] [Abstract][Full Text] [Related]
4. The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancers. Chelariu-Raicu A; Zibetti Dal Molin G; Coleman RL Int J Gynecol Cancer; 2020 Oct; 30(10):1608-1618. PubMed ID: 32928926 [TBL] [Abstract][Full Text] [Related]
5. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells. Singh S; Kumar PU; Thakur S; Kiran S; Sen B; Sharma S; Rao VV; Poongothai AR; Ramakrishna G Tumour Biol; 2015 Aug; 36(8):6159-71. PubMed ID: 25794641 [TBL] [Abstract][Full Text] [Related]
6. 17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylation. Bendale DS; Karpe PA; Chhabra R; Shete SP; Shah H; Tikoo K Br J Pharmacol; 2013 Oct; 170(4):779-95. PubMed ID: 23826814 [TBL] [Abstract][Full Text] [Related]
7. Sirtuin 1 promotes autophagy and proliferation of endometrial cancer cells by reducing acetylation level of LC3. Huang S; Li Y; Sheng G; Meng Q; Hu Q; Gao X; Shang Z; Lv Q Cell Biol Int; 2021 May; 45(5):1050-1059. PubMed ID: 33438275 [TBL] [Abstract][Full Text] [Related]
8. Sirt1 physically interacts with Tip60 and negatively regulates Tip60-mediated acetylation of H2AX. Yamagata K; Kitabayashi I Biochem Biophys Res Commun; 2009 Dec; 390(4):1355-60. PubMed ID: 19895790 [TBL] [Abstract][Full Text] [Related]
9. Multifaceted Modulation of SIRT1 in Cancer and Inflammation. Yang H; Bi Y; Xue L; Wang J; Lu Y; Zhang Z; Chen X; Chu Y; Yang R; Wang R; Liu G Crit Rev Oncog; 2015; 20(1-2):49-64. PubMed ID: 25746104 [TBL] [Abstract][Full Text] [Related]
10. A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer. Li D; Bi FF; Chen NN; Cao JM; Sun WP; Zhou YM; Li CY; Yang Q Sci Rep; 2014 Oct; 4():6666. PubMed ID: 25323003 [TBL] [Abstract][Full Text] [Related]
11. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide. Hajji N; Wallenborg K; Vlachos P; Füllgrabe J; Hermanson O; Joseph B Oncogene; 2010 Apr; 29(15):2192-204. PubMed ID: 20118981 [TBL] [Abstract][Full Text] [Related]
12. Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target. Wu Y; Meng X; Huang C; Li J Tumour Biol; 2015 Jun; 36(6):4063-74. PubMed ID: 25926383 [TBL] [Abstract][Full Text] [Related]
13. A bioinformatics analysis of the clinicopathological and prognostic significance of Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120 [TBL] [Abstract][Full Text] [Related]
14. Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3. Tong X; Wang X; Wang C; Li L Br J Biomed Sci; 2018 Jan; 75(1):7-12. PubMed ID: 28929922 [TBL] [Abstract][Full Text] [Related]
15. The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer. Alves-Fernandes DK; Jasiulionis MG Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261609 [TBL] [Abstract][Full Text] [Related]
16. Negative transcriptional regulation of inflammatory genes by group B3 vitamin nicotinamide. Zhang XM; Jing YP; Jia MY; Zhang L Mol Biol Rep; 2012 Dec; 39(12):10367-71. PubMed ID: 23053940 [TBL] [Abstract][Full Text] [Related]
17. Sirtuin1-p53: A potential axis for cancer therapy. Yin JY; Lu XT; Hou ML; Cao T; Tian Z Biochem Pharmacol; 2023 Jun; 212():115543. PubMed ID: 37037265 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer. Kiga K; Fukuda-Yuzawa Y; Tanabe M; Tsuji S; Sasakawa C; Fukao T RNA Biol; 2014; 11(11):1347-54. PubMed ID: 25483038 [TBL] [Abstract][Full Text] [Related]
19. SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis. Lin L; Zheng X; Qiu C; Dongol S; Lv Q; Jiang J; Kong B; Wang C Oncol Rep; 2014 Dec; 32(6):2831-5. PubMed ID: 25270091 [TBL] [Abstract][Full Text] [Related]
20. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Hu N; Long H; Zhao M; Yin H; Lu Q Scand J Rheumatol; 2009; 38(6):464-71. PubMed ID: 19922023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]